Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Systemic therapy for colorectal cancer].

B C Pestalozzi1, D Jäger, A Knuth

  • 1Klinik und Poliklinik für Onkologie, Universitätsspital Zürich, Schweiz.

Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|May 21, 2005
PubMed
Summary

Recent advancements in colorectal cancer treatment include new drugs like irinotecan and oxaliplatin, alongside monoclonal antibodies such as bevacizumab and cetuximab. Evidence from clinical trials informs rational treatment strategies for improved patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of nutritional risk screening on outcomes of first-line treatment in metastatic esophagogastric adenocarcinoma: a secondary analysis of the AIO-MATEO trial.

ESMO gastrointestinal oncology·2026
Same author

TROPHIT1-a randomized, open-label, multicenter, phase II/III trial of sacituzumab govitecan compared to standard of care in metastatic colorectal cancer patients.

ESMO gastrointestinal oncology·2026
Same author

Effectiveness, toxicity and treatment adjustments of lenvatinib plus pembrolizumab in advanced renal cell carcinoma: a multicenter real-world analysis.

ESMO real world data and digital oncology·2026
Same author

CDK4/6 inhibition in advanced chordoma: final results of the NCT PMO-1601 trial.

ESMO open·2025
Same author

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Same author

COGNITION: a prospective precision oncology trial for patients with early breast cancer at high risk following neoadjuvant chemotherapy.

ESMO open·2022

Area of Science:

  • Oncology
  • Pharmacology
  • Clinical Medicine

Background:

  • Colorectal cancer treatment has significantly evolved over the last decade.
  • Traditional chemotherapy agents like 5-fluorouracil remain important.
  • Emerging targeted therapies and immunotherapies are transforming patient care.

Purpose of the Study:

  • To review recent progress in drug treatment for colorectal cancer.
  • To discuss the integration of novel anticancer drugs and monoclonal antibodies.
  • To outline evidence-based, rational treatment strategies.

Main Methods:

  • Analysis of data from randomized clinical trials.
  • Review of established and novel therapeutic agents.
  • Synthesis of current treatment guidelines and practices.

Related Experiment Videos

Main Results:

  • Significant progress in colorectal cancer treatment efficacy.
  • Availability of new drugs including irinotecan and oxaliplatin.
  • Integration of monoclonal antibodies like bevacizumab and cetuximab into standard regimens.

Conclusions:

  • Modern colorectal cancer treatment incorporates a diverse range of effective drugs.
  • Randomized clinical trials provide the basis for rational therapeutic decision-making.
  • Optimized treatment strategies are crucial for improving patient survival and quality of life.